Pulse Biosciences, Inc (PLSE): Price and Financial Metrics
GET POWR RATINGS... FREE!
PLSE Stock Price Chart Interactive Chart >
PLSE Price/Volume Stats
| Current price | $16.90 | 52-week high | $45.82 |
| Prev. close | $17.41 | 52-week low | $8.76 |
| Day low | $16.82 | Volume | 41,029 |
| Day high | $17.41 | Avg. volume | 112,098 |
| 50-day MA | $18.90 | Dividend yield | N/A |
| 200-day MA | $20.61 | Market Cap | 447.17M |
Pulse Biosciences, Inc (PLSE) Company Bio
Pulse Biosciences, a development stage medical device company, focuses on developing medical technologies based on sub-microsecond pulsed electric field technology to detect and treat skin cancer and enhance wound healing. The company was founded in 2014 and is based in Burlingame, California.
Latest PLSE News From Around the Web
Below are the latest news stories about Pulse Biosciences Inc that investors may wish to consider to help them evaluate PLSE as an investment opportunity.
Moving Average Crossover Alert: Pulse Biosciences (PLSE)Pulse Biosciences (PLSE) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. |
New Strong Sell Stocks for June 9thFLY, PLSE, YTRA, GHL, and TELL have been added to the Zacks Rank #5 (Strong Sell) List on June 9, 2021. |
Pulse Biosciences Announces Health Canada Approval for CellFX® SystemPulse Biosciences Announces Health Canada Approval for CellFX ® System - Company to Expand Global Controlled Launch Program with Clinical Aesthetic Experts in Canada. |
Pulse Biosciences to Participate in the Jefferies Healthcare ConferencePulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company introducing the CellFX System powered by Nano-Pulse Stimulation (NPS) technology, today announced plans to participate in the Jefferies Virtual Healthcare Conference. Management is scheduled to present at 12:30pm PT on Wednesday, June 2, 2021. |
Pulse Biosciences Presents Clinical Study Results of Nano-Pulse Stimulation Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual ConferencePulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company introducing the CellFX System powered by Nano-Pulse Stimulation (NPS) technology, today announced the podium presentation of four clinical studies of NPS technology at the American Society for Laser Medicine and Surgery (ASLMS) Virtual Annual Meeting taking place on May 15-16, 2021. Recent results will be presented on |
PLSE Price Returns
| 1-mo | -4.14% |
| 3-mo | -28.33% |
| 6-mo | -23.56% |
| 1-year | 57.80% |
| 3-year | 3.74% |
| 5-year | 286.73% |
| YTD | -29.17% |
| 2020 | 77.93% |
| 2019 | 17.02% |
| 2018 | -51.44% |
| 2017 | 263.08% |
| 2016 | N/A |
Loading social stream, please wait...